" class="no-js "lang="en-US"> Aasma Shaukat - Medtech Alert
Sunday, August 03, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Aasma Shaukat

Aasma Shaukat

About Aasma Shaukat

Aasma Shaukat, MD, MPH, a renowned leader in the field of gastroenterology, has joined NYU Langone Health as the director of outcomes research in the Division of Gastroenterology and Hepatology.

Related Story

Artificial Intelligence

 New Research Finds Computer Assisted Colonoscopy Identify More Precancerous Polyps Compared to Traditional Colonoscopy | Pharmtech Focus

New Research Finds Computer Assisted Colonoscopy Identify More Precancerous Polyps Compared to Traditional Colonoscopy

May 24 2022

Colonoscopies performed with computer-aided detection, or artificial intelligence, (AI) saw an increase in the overall […]

Clinical Trials

 Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment | Pharmtech Focus

Largest Clinical Study Validating A Blood-based Colorectal Screening Test Completes Enrollment

May 11 2022

Freenome, a privately held biotech company, announced the completion of enrollment for PREEMPT CRC, the […]